Bain Capital Life Sciences Fund L.P. 13D and 13G filings for Dynavax Technologies Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-17 5:00 pm Sale | 2022-08-15 | 13D | Dynavax Technologies Corporation DVAX | Bain Capital Life Sciences Fund L.P. | 4,912,610 3.900% | -2,721,435 (-35.65%) | Filing |
| 2021-08-27 5:17 pm Sale | 2021-08-27 | 13D | Dynavax Technologies Corporation DVAX | Bain Capital Life Sciences Fund L.P. | 7,634,045 6.400% | -2,780,955 (-26.70%) | Filing |
| 2021-08-11 5:16 pm Sale | 2021-08-09 | 13D | Dynavax Technologies Corporation DVAX | Bain Capital Life Sciences Fund L.P. | 10,415,000 13.000% | -1,356,708 (-11.53%) | Filing |
| 2021-06-11 5:16 pm Purchase | 2021-06-10 | 13D | Dynavax Technologies Corporation DVAX | Bain Capital Life Sciences Fund L.P. | 11,771,708 13.000% | 875,935 (+8.04%) | Filing |
| 2020-05-28 5:11 pm Purchase | 2020-05-27 | 13D | Dynavax Technologies Corporation DVAX | Bain Capital Life Sciences Fund L.P. | 10,895,773 13.000% | 2,165,066 (+24.80%) | Filing |